ArticleOncology letters2017

Thalidomide inhibits proliferation and epithelial-mesenchymal transition by modulating CD133 expression in pancreatic cancer cells.

Congying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.